Nmda Receptor Antagonists

NMDA Receptor Antagonists is a class of pharmacological agents that selectively inhibit the activity of N-methyl-D-aspartate (NMDA) receptors, thereby modulating glutamatergic neurotransmission implicated in central sensitization and chronic neuropathic pain.

5.3K

Publications

382.4K

Citations

16.6K

Authors

2.7K

Institutions

Publications per year

2017–2026

423

Authors

16.6K

  1. WD
    Wojciech Danysz

    MerLion Pharma (Germany), Germany

    43 publications · 3.3K citations

    29

    h-index

  2. CG
    Chris G. Parsons

    Merz (Germany), Germany

    30 publications · 2.8K citations

    23

    h-index

  3. RM
    Richard M. Woodward

    University of California, Irvine, United States

    26 publications · 1.1K citations

    21

    h-index

  4. AB
    Anton Bespalov

    First Pavlov State Medical University of St. Petersburg, Russia

    27 publications · 886 citations

    20

    h-index

  5. JA
    John A. Kemp

    Roche (Switzerland), Switzerland

    21 publications · 2.6K citations

    20

    h-index

1–5 of 16.6K

Venues

  1. Journal of Neuroscience

    290 publications · 56.3K citations

    135

    h-index

  2. 71

    h-index

  3. Journal of Neurochemistry

    JNC · 204 publications · 15.8K citations

    70

    h-index

  4. Pain

    119 publications · 13.8K citations

    66

    h-index

  5. Brain Research

    186 publications · 10K citations

    56

    h-index

1–5